Chemoinformaics analysis of 2,2-Dimethyl-3,4-octadienal
| Molecular Weight | 152.237 | nRot | 4 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 3 |
| Exact Molecular Weight | 152.12 | nRing | 0 |
| Solubility: LogS | -2.51 | nHRing | 0 |
| Solubility: LogP | 2.796 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.1707 |
| nHD | 0 | BPOL | 16.9193 |
| QED | 0.447 |
| Synth | 3.921 |
| Natural Product Likeliness | 1.304 |
| NR-PPAR-gamma | 0.382 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.636 |
| Pgp-sub | 0.002 |
| HIA | 0.003 |
| CACO-2 | -4.518 |
| MDCK | 0.0000156 |
| BBB | 0.78 |
| PPB | 0.563979 |
| VDSS | 2.316 |
| FU | 0.609711 |
| CYP1A2-inh | 0.022 |
| CYP1A2-sub | 0.283 |
| CYP2c19-inh | 0.018 |
| CYP2c19-sub | 0.641 |
| CYP2c9-inh | 0.018 |
| CYP2c9-sub | 0.243 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.03 |
| CYP3a4-inh | 0.048 |
| CYP3a4-sub | 0.234 |
| CL | 6.589 |
| T12 | 0.659 |
| hERG | 0.049 |
| Ames | 0.026 |
| ROA | 0.033 |
| SkinSen | 0.975 |
| Carcinogencity | 0.73 |
| EI | 0.983 |
| Respiratory | 0.93 |
| NR-Aromatase | 0.05 |
| Antiviral | No |
| Prediction | 0.946846 |